Trinity Biotech (TRIB) Receivables - Other (2023 - 2025)

Trinity Biotech has disclosed Receivables - Other across 3 years of filings, most recently posting $16000.0 for Q4 2025.

• Receivables - Other for Q4 2025 came in at $16000.0, down 90.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $16000.0 (down 90.48% YoY), and the FY2025 annual result was $16000.0, down 90.48% from the prior year.
• Receivables - Other came in at $16000.0 for Q4 2025 at Trinity Biotech, down from $168000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $168000.0 in Q4 2024 to a low of $16000.0 in Q4 2025.
• The 3-year median for Receivables - Other is $107000.0 (2023), against an average of $97000.0.
• Across the five-year window, Receivables - Other jumped 57.01% in 2024 and plunged 90.48% in 2025, its largest moves.
• Trinity Biotech's Receivables - Other stood at $107000.0 in 2023, then surged by 57.01% to $168000.0 in 2024, then slumped by 90.48% to $16000.0 in 2025.
• The last three Receivables - Other figures came in at $16000.0 (Q4 2025), $168000.0 (Q4 2024), and $107000.0 (Q4 2023), per Business Quant data.